In this publication, CX3CL1 directly promoted proliferation and therapy resistance of pancreatic cancer cells by leading to enrichment of pancreatic cancer cells in S phase with a concomitant decrease of the number of cells in G1 phase [67]. This evidence concerns the gene CX3CL1 and pancreatic neoplasm.